Skip to main content
Download PDF

Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer

Journal of Hematology & Oncology volume 12, Article number: 83 (2019) Cite this article

The Original Article was published on 10 June 2019

Correction to: J Hematol Oncol (2019) 12:56

https://doi.org/10.1186/s13045-019-0740-7

The original article [1] contains an error in Fig. 2 whereby Fig. 2d has mistakenly been omitted. Figure 2 can be viewed in its entirety – including Fig. 2d – in this Correction article.

Fig. 2
figure 1

Characterization of tumor derived exosomes and EVs. The size and morphology of exosomes were evaluated by dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) (a) and transmission electron microscopy (TEM) (b), respectively. The yield of DNA was 3.4-fold higher in LXY30-enriched exosomes than in S-LXY30-enriched exosomes (3.4 ± 0.7 vs 1.0 ± 0.2 ng/μL, p = 0.014) (c). Driven mutations (EGFR L858R and T790 M in H1975) were detected by PCR and Sanger sequencing in the DNA isolated from LXY30 exosomes (d)

Full size image

Reference

  1. Xiao W, Ma W, Wei S, Li Q, Liu R, Carney RP, et al. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer. J Hematol Oncol. 2019;12:56 https://doi.org/10.1186/s13045-019-0740-7.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Wenwu Xiao and Weijie Ma contributed equally to this work.

Authors and Affiliations

  1. Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, 95817, USA

    Wenwu Xiao, Ruiwu Liu, Alan Nyugen & Kit S. Lam

  2. Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, University of California Davis Comprehensive Cancer Center, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA

    Weijie Ma, Sixi Wei, Qianping Li, Kevin Yang, Kit S. Lam & Tianhong Li

  3. Present Address: Department of Biochemistry, Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou, China

    Sixi Wei

  4. Present Address: Department of Cardiothoracic Surgery, Shanghai Jiaotong University Affiliated Sixth People’s Hospital, 600 Yi-Shan Road, Shanghai, 200233, China

    Qianping Li

  5. Department of Biomedical Engineering, University of California Davis, Davis, CA, USA

    Randy P. Carney

  6. Present Address: Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Kevin Yang

  7. Department of Pharmacy, University of California Davis Health System, Sacramento, CA, 95817, USA

    Joyce Lee

  8. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA, USA

    Ken Y. Yoneda

  9. Department of Internal Medicine, Veterans Affairs Northern California Health Care System, Mather, CA, USA

    Ken Y. Yoneda & Tianhong Li

Authors
  1. Wenwu Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Weijie Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sixi Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qianping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ruiwu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Randy P. Carney
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kevin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Joyce Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Alan Nyugen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ken Y. Yoneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kit S. Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Tianhong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Kit S. Lam or Tianhong Li.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xiao, W., Ma, W., Wei, S. et al. Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer. J Hematol Oncol 12, 83 (2019). https://doi.org/10.1186/s13045-019-0764-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13045-019-0764-z

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us